1Tamargo I, Fuentes K, Llop A, et al. High levels of multiple antibiotic resistance among 938 haemophilus influenzae type b meningitis isolates from Cuba (1990-2002). [J]. J-Antimicrob-Chemother, 2003, 52 (4): 695-698.
2Randall L P, Ridley AM, Cooles SW, et al. Prevalence of multiple antibiotic resistance in 443 campylobacter spp.Isolated from humans and animals[J]. J-Antimicrob-Chemother, 2003, 52(3): 507-510.
3Giamarellou H. Multidrug resistance in gram-negative bacteria that produce extended spectrum beta-lactamases(ESBLs)[J]. Clin Microbiol Infect, 2005, 11 (Suppl4):1-16.
4Blahova J, Kralikova K, Krcmery V Sr, et al. Host range variability in the transfer of antibiotic resistance determinants from pseudomonas aeruginosa strains[J]. J Chemother, 2000, 12(3): 199-203.
5Wang H, Yu Y, Xie X, et al. B. Bedenic. In-vitro antibacterial activities of cefpiramide and other broad-spectrum antibiotics against 440 clinical isolates in china[J]. Journal of Infection and Chemotherapy, 2000, 6(12) : 81-85.
6Glupczynski Y, Delmee M, Goossens H, et al.Distribution and prevalence of antimicrobial resistance among gram-negative isolates in intensive care units(ICU)in Belgian hospitals between 1996 and 1999 [J]. Acta-Clin-Belg, 2001, 56(5): 297-306.
7Barlow M, Hall BG. Experimental prediction of the natural evolution of antibiotic resistance[J]. Genetics,2003,163(4): 1237-1247.
8Wilcox MH. Antibiotic presenbing as a risk factor for MRSA[J].Hosp Med, 2005, 66(3): 180-184.
9Virdi JS, Sinha I, Rajendran P, et al. Arsenite-induced multiple antibiotic resistance phenotype in environmental isolates of Yersinia enterocolitica[J]. Current Microbiology,2001, 43(2): 144-146.
